ES548529A0 - Procedimiento de modificacion de celulas eucariotas. - Google Patents

Procedimiento de modificacion de celulas eucariotas.

Info

Publication number
ES548529A0
ES548529A0 ES548529A ES548529A ES548529A0 ES 548529 A0 ES548529 A0 ES 548529A0 ES 548529 A ES548529 A ES 548529A ES 548529 A ES548529 A ES 548529A ES 548529 A0 ES548529 A0 ES 548529A0
Authority
ES
Spain
Prior art keywords
pct
euchariot
cells
modification
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES548529A
Other languages
English (en)
Other versions
ES8900170A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Recherche Agronomique INRA
Original Assignee
Institut National de la Recherche Agronomique INRA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Recherche Agronomique INRA filed Critical Institut National de la Recherche Agronomique INRA
Publication of ES548529A0 publication Critical patent/ES548529A0/es
Publication of ES8900170A1 publication Critical patent/ES8900170A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
ES548529A 1984-10-15 1985-10-15 Procedimiento de modificacion de celulas eucariotas. Expired ES8900170A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8415764A FR2571737B1 (fr) 1984-10-15 1984-10-15 Vecteurs de clonage ou d'expression comportant le genome du virus de l'erythroblastose aviaire et cellules transfectees par ces vecteurs

Publications (2)

Publication Number Publication Date
ES548529A0 true ES548529A0 (es) 1988-04-16
ES8900170A1 ES8900170A1 (es) 1988-04-16

Family

ID=9308658

Family Applications (2)

Application Number Title Priority Date Filing Date
ES548529A Expired ES8900170A1 (es) 1984-10-15 1985-10-15 Procedimiento de modificacion de celulas eucariotas.
ES557463A Expired ES8800985A1 (es) 1984-10-15 1987-02-27 Procedimiento de preparar proteinas.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES557463A Expired ES8800985A1 (es) 1984-10-15 1987-02-27 Procedimiento de preparar proteinas.

Country Status (16)

Country Link
US (1) US4957865A (es)
EP (1) EP0178996B1 (es)
JP (1) JPS62501398A (es)
AT (1) ATE48642T1 (es)
AU (1) AU5010585A (es)
BR (1) BR8506990A (es)
DE (1) DE3574732D1 (es)
DK (1) DK279686A (es)
ES (2) ES8900170A1 (es)
FI (1) FI862517A7 (es)
FR (1) FR2571737B1 (es)
GR (1) GR852500B (es)
NO (1) NO862383D0 (es)
PT (1) PT81306B (es)
WO (1) WO1986002380A1 (es)
ZA (1) ZA857862B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1310924C (en) * 1986-04-24 1992-12-01 Francis P. Mccormick Infective drug delivery system
FR2606030B1 (fr) * 1986-10-31 1989-10-20 Pasteur Institut Retrovirus recombinant defectif, son procede de fabrication et ses applications, notamment pour l'etude de l'interaction des retrovirus sauvages avec des lignees cellulaires infectables par celui-ci
US5256553A (en) * 1987-10-09 1993-10-26 Immunex Corporation Multiple promoter transforming retroviral vectors
FR2622207B1 (fr) * 1987-10-21 1990-03-09 Agronomique Inst Nat Rech Vecteurs d'integration et d'expression d'un gene heterologue, cellules infectees avec ces vecteurs et procede de production d'une proteine ou de modification genetique d'animaux
FR2631974B1 (fr) * 1988-05-31 1992-12-11 Agronomique Inst Nat Rech Baculovirus modifie, son procede de preparation et son application en tant que vecteur d'expression de genes
US6027722A (en) * 1990-10-25 2000-02-22 Nature Technology Corporation Vectors for gene transfer
ATE169061T1 (de) * 1990-10-25 1998-08-15 Clague Pitman Hodgson Methode des gentransfers mittels retrotransposons
US6300058B1 (en) * 1992-01-29 2001-10-09 Hitachi Chemical Research Center, Inc. Method for measuring messenger RNA
WO1994020608A1 (en) 1993-03-12 1994-09-15 Creighton University Improved vectors for gene therapy
US5808043A (en) * 1995-01-18 1998-09-15 Pharmacia Biotech Inc. Composition for stabilization of labelled nucleoside triphosphates and methods for using same
US20030190753A1 (en) * 1995-11-09 2003-10-09 Nature Technology Corporation Vectors for gene transfer
CA2350111A1 (en) * 1998-11-16 2000-05-25 Genway Biotech, Inc. Generation of antibodies using polynucleotide vaccination in avian species
US20070082354A1 (en) * 2005-09-26 2007-04-12 Nexttec Gmbh Method for Isolating RNA

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405712A (en) * 1981-07-01 1983-09-20 The United States Of America As Represented By The Department Of Health And Human Services LTR-Vectors
EP0105141A3 (en) * 1982-09-09 1985-12-04 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Recombinant dna molecules, process for their production, their use for production of hepatitis b surface antigen (hbsag) and pharmaceutical compositions containing this hbsag
FR2559159B1 (fr) * 1984-02-02 1986-09-12 Inst Nat Sante Rech Med Vecteurs viraux de clonage et d'expression d'une proteine dans une cellule eucaryote, comportant au moins une partie du genome d'un retro-virus; cellules eucaryotes transfectees; procede utilisant de telles cellules et proteines obtenues
US4686098A (en) * 1984-05-14 1987-08-11 Merck & Co., Inc. Encapsulated mouse cells transformed with avian retrovirus-bovine growth hormone DNA, and a method of administering BGH in vivo

Also Published As

Publication number Publication date
FR2571737B1 (fr) 1987-02-20
NO862383L (no) 1986-06-16
ATE48642T1 (de) 1989-12-15
PT81306A (fr) 1985-11-01
JPS62501398A (ja) 1987-06-11
ES557463A0 (es) 1987-12-16
US4957865A (en) 1990-09-18
FR2571737A1 (fr) 1986-04-18
FI862517A0 (fi) 1986-06-12
ZA857862B (en) 1986-05-28
BR8506990A (pt) 1987-01-06
AU5010585A (en) 1986-05-02
DK279686D0 (da) 1986-06-13
NO862383D0 (no) 1986-06-16
DK279686A (da) 1986-06-13
DE3574732D1 (de) 1990-01-18
GR852500B (es) 1986-02-18
EP0178996A1 (fr) 1986-04-23
PT81306B (fr) 1987-03-25
FI862517L (fi) 1986-06-12
FI862517A7 (fi) 1986-06-12
ES8800985A1 (es) 1987-12-16
WO1986002380A1 (fr) 1986-04-24
ES8900170A1 (es) 1988-04-16
EP0178996B1 (fr) 1989-12-13

Similar Documents

Publication Publication Date Title
ES557463A0 (es) Procedimiento de preparar proteinas.
DE69841105D1 (de) Chemokine peptide, varianten, derivate und analoge. ihre verwendung in methode für die hemmung oder erhöhung von einer entzündungsreaktion
DE3579113D1 (de) Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden.
ES2194029T3 (es) Variantes del virus hiv-2.
DE69819167D1 (de) Modifizierter, das dorsalgewebe beeinflussender faktor
NO861700L (no) Slitasjeresistent og korrosjonsbeskyttende, keramisk kromoksydbelegg.
ATE315667T1 (de) Amplifizierung und detektion von hiv-1 und/oder hiv-2
ES295795Y (es) Una disposicion de mango y hoja de bisturi o escarpelo.
DK0486515T3 (da) Fremgangsmåde til bestemmelse af den funktionelle aktivitet af frit protein S eller protein C i en plasmaprøve
BR9607543A (pt) Inibidores de protease retroviral sulfonamida hidroxietilamino de bis-amino ácido
DE69107733D1 (de) Titanium-enthaltende Mittel zur Verhinderung von Ablagerungen bei thermischen Crackprozessen.
FI875544A0 (fi) Anvaendning av 3'-deoxitymidin-2'-en (3'-deoxi-2',3'-didehydrotymidin) foer behandling av patienter infekterade med retrovirus.
FI883034A0 (fi) Vattentaet skjutdoerr med uppblaosbar eller aktiverbar taetning.
PE20000759A1 (es) Gen de la citocroma oxidasa de hidroquinona del tipo bd
DE3789525D1 (de) Das F-Protein vom AIDS-Virus enthaltender Impfstoff.
NO885645D0 (no) Beskyttende belegg for baererstavene til forbrente anoder og den utstikkende del hos anodene.
ATE262307T1 (de) Verwendung von goldlegierungen für konstruktionselemente in der dentaltechnik
FR2621816B1 (fr) Application antivirale des ologonucleotides
FR2720756B1 (fr) Virus recombinants, préparation et utilisation en thérapie génique.
ATE44801T1 (de) Vorrichtung zur behandlung von rauchgas, insbesondere auspuffgas.
DE3771490D1 (de) Filiformkorrosionsresistente primerzusammensetzung und methode zur verhuetung von filiformkorrosion.
IT8460936V0 (it) Macchina per lavaggio automatico di strumenti odontoiatrici vassoi e simili.
FI882509A7 (fi) Matalajaksoinen väsytyskoestuslaite.
ATE104147T1 (de) Verwendung von inositol-triphosphat zur behandlung von metallvergiftung.